|
|
 |
|
Viewing report
|
|
|
|
16#
Sunfaith China Ltd, Nov 2004, Pages: 10
The report first analyzes the occurrences of the asthma in China, pointing out that the market space for the anti-asthma drugs is fairly large due to its high incidence, huge number of affecters and serious harm. It then gives a general description on China’s anti-asthma drug market. In the hospital market, Western medicines such as the Anti-Inflammatory drugs take a large market share, whereas in the OTC market, the sales of the Chinese traditional medicines are higher.
The report points out that hormone inhaler has always been the most important drug in the whole anti-asthma drug market, however, in recent years, its market share is in the declining trend. The market share of Adrenocept inhaler, following the hormone inhaler in the market share, has enjoyed a rapid growth because of its unsubstutional position in easing acute symptom.
The report analyzes some famous brands of China’s anti-asthma drugs on the basis of a group of statistics. Foreign drugs take the prominent role in this market. The report lays emphasis on the centralization of this market.
Customers who bought this item also bought
Report on China’s Anti-Asthma Drug Market
Report on China’s Anti-Asthma Medicine Market
China Asthma Drug Market Report 2008
Commercial Insight: Asthma & COPD - On the verge of generic entry
European Asthma Therapeutics Markets
China Anti-tumor Drugs Market Report 2007
China Anti-tumor Drugs Market Report, 2007
Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential
U.S. Asthma Therapies Markets
China Anti-Diabetic Drug Market Report 2008
U.S. Asthma Therapeutics Market
Asthma & COPD Therapeutics
|
|
|
|
